Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.

Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A; Eliminate Hepatitis C Partnership

(2021), J VIRAL HEPATITIS, 28(3), 569-572

DOI: 10.1111/jvh.13447

Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort

Carson JM, Hajarizadeh B, Hanson J, O'Beirne J, Iser D, Read P, Balcomb A, Davies J, Doyle JS, Yee J, Martinello M, Marks P, Dore GJ, Matthews GV; REACH-C Study Group

(2021), Int J Drug Policy, 96, 103422

DOI: 10.1016/j.drugpo.2021.103422

Building on Antimicrobial Stewardship Programs Through Integration with Electronic Medical Records: The Australian Experience

Cairns KA, Rawlins MDM, Unwin SD, Doukas FF, Burke R, Tong E, Henderson AJ, Cheng AC

(2021), Infect Dis Ther, 10(1), 61-73

DOI: 10.1007/s40121-020-00392-5

Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review

Cairns KA, Hall V, Martin GE, Griffin DWJ, Stewart JD, Khan SF, Abbott IJ, Meher-Homji Z, Morrissey CO, Sia C, Love J, Corallo CE, Bergin P, Sharma A, Basu G, Spencer A, Peleg AY

(2021), Transpl Infect Dis, 23(2), e13510

DOI: 10.1111/tid.13510

Ventricular Assist Device-Specific Infections

Qu Y, Peleg AY, McGiffin D

(2021), J Clin Med, 10(3), 453

DOI: 10.3390/jcm10030453

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haematopoietic stem cell transplantation, 2021

Teh BW, Yeoh DK, Haeusler GM, Yannakou CK, Fleming S, Lindsay J, Slavin MA; Australasian Antifungal Guidelines Steering Committee

(2021), Intern Med J, 51 Suppl7, 67-88

DOI: 10.1111/imj.15588

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Chang CC, Hall V, Cooper C, Grigoriadis G, Beardsley J, Sorrell TC, Heath CH; and the Australasian Antifungal Guidelines Steering Committee.

(2021), Intern Med J, 51 Suppl7, 118-42

DOI: 10.1111/imj.15590

A 44-year-old man with an ulcerating skin rash in the setting of advanced human immunodeficiency virus infection

MacPhail AI, McLean C, Vujovic O, Hoy JF

(2021), AIDS, 35(8), 1325-6

DOI: 10.1097/QAD.0000000000002860

Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 'superplasmids' in clinical carbapenem-resistant Enterobacterales

Macesic N, Blakeway LV, Stewart JD, Hawkey J, Wyres KL, Judd LM, Wick RR, Jenney AW, Holt KE, Peleg AY

(2021), CLIN MICROBIOL INFEC, 27(12), 1856.e7-1856.e13

DOI: 10.1016/j.cmi.2021.04.020

Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients

Wyres KL, Hawkey J, Mirčeta M, Judd LM, Wick RR, Gorrie CL, Pratt NF, Garlick JS, Watson KM, Pilcher DV, McGloughlin SA, Abbott IJ, Macesic N, Spelman DW, Jenney AWJ, Holt KE

(2021), BMC Infect Dis, 21(1), 683

DOI: 10.1186/s12879-021-06386-z

Development and piloting of a prevention assessment and response tool for healthcare-associated Staphylococcus aureus bloodstream infection (the SAB-PART Study) using a Delphi method

Karanfilovska D, Cheng AC, Spelman D, Worth LJ

(2021), J Hosp Infect, 115, 17-26

DOI: 10.1016/j.jhin.2021.06.001

Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV

Ashok A, Hoy J, Spelman D, McMahon J, Pai Mangalore R

(2021), AIDS, 35(1), 157-8

DOI: 10.1097/QAD.0000000000002702

Transmitted Donor Immunology Not Infection: Common Persistence of Donor Hepatitis C Antibody Production in Aviremic Lung Transplant Recipients

Smibert OC, Doyle JS, Jenney AW, Pilcher D, Paraskeva MA, Westall GP, Snell GI

(2021), OBM Transplantation, 5(1), 11

DOI: 10.21926/obm.transplant.2101134

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Nguyen THO, Rowntree LC, Petersen J, Chua BY, Hensen L, Kedzierski L, van de Sandt CE, Chaurasia P, Tan HX, Habel JR, Zhang W, Allen LF, Earnest L, Mak KY, Juno JA, Wragg K, Mordant FL, Amanat F, Krammer F, Mifsud NA, Doolan DL, Flanagan KL, Sonda S, Kaur J, Wakim LM, Westall GP, James F, Mouhtouris E, Gordon CL, Holmes NE, Smibert OC, Trubiano JA, Cheng AC, Harcourt P, Clifton P, Crawford JC, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Torresi J, Kedzierska K

(2021), Immunity, 54(5), 1066-82

DOI: 10.1016/j.immuni.2021.04.009

Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care

Harney BL, Brereton R, Whitton B, Pietrzak D, Paige E, Roberts SK, Birks S, Saraf S, Hellard ME, Doyle JS

(2021), J VIRAL HEPATITIS, 28(5), 771-8

DOI: 10.1111/jvh.13487

Search and Contain: Impact of an integrated genomic and epidemiological surveillance and response program for control of carbapenemase-producing Enterobacterales

Lane CR, Brett J, Schultz M, Gorrie CL, Stevens K, Cameron DRM, St George S, van Diemen A, Easton M, Stuart RL, Sait M, Peleg AY, Stewardson AJ, Cheng AC, Spelman DW, Waters MJ, Ballard SA, Sherry NL, Williamson DA, Romanes F, Sutton B, Kwong JC, Seemann T, Goncalves da Silva A, Stephens N, Howden BP

(2021), Clin Infect Dis, 73(11), e3912-20

DOI: 10.1093/cid/ciaa972

The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services

Traeger, Michael W.; Pedrana, Alisa E.; van Santen, Daniela K.; Doyle, Joseph S.; Howell, Jessica; Thompson, Alexander J.; El-Hayek, Carol; Asselin, Jason; Polkinghorne, Victoria; Membrey, Dean; Bramwell, Fran; Carter, Allison; Guy, Rebecca; Stoové, Mark

(2020), PLOS ONE, 15(6), e0235445.

DOI: 10.1371/journal.pone.0235445

The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018

Blyth, Christopher C.; Cheng, Allen C.; Crawford, Nigel W.; Clark, Julia E.; Buttery, Jim P.; Marshall, Helen S.; Francis, Joshua R.; McRae, Jocelynne; Kotsimbos, Tom; Kelly, Paul M.; Macartney, Kristine K.

(2020), VACCINE, 38(13), 2779-2787.

DOI: 10.1016/j.vaccine.2020.02.031

The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C

van Santen, Daniela K.; Agius, Paul A.; Sasadeusz, Joseph; Fairley, Christopher K.; Sievert, William; Gane, Edward; Iser, David; OʼReilly, Mark; Medland, Nicholas A.; Moore, Richard; Hellard, Margaret E.; Hoy, Jennifer F.; Doyle, Joseph S.; ,

(2020), JAIDS-J ACQ IMM DEF, 85(5), e81-e89.

DOI: 10.1097/QAI.0000000000002487

The elimination of hepatitis C as a public health threat

Hellard, Margaret; Schroeder, Sophia E.; Pedrana, Alisa; Doyle, Joseph; Aitken, Campbell

(2020), CSH PERSPECT MED, 10(4), a036939.

DOI: 10.1101/cshperspect.a036939